New FDA-approved drug for vision loss now available at Retina Health Center
Following a three-year year clinical study at Retina Health Center and other participating eye centers around the country, the FDA has approved the use of the injectable drug Lucentis for the treatment of diabetic macular edema. Diabetic macular edema occurs when fluid accumulates on or under the macular (the center of the retina) and causes it to thicken or swell. As swelling develops, blurring occurs and vision loss may progress over time. Until now, there has been no approved drug to treat diabetic macular edema. For the past 30 years, the condition has been treated with laser surgery